Journal profile · Nursing-Oncology (nursing)
Technical Innovations and Patient Support in Radiation Oncology
ISSN 2405-6324 · Elsevier · Netherlands
Technical Innovations and Patient Support in Radiation Oncology: CAS Zone 3 · Medicine (2026 Xinrui edition); impact factor 2 (journal website); fully open access; APC about USD 1,410; median 89 days to acceptance (101 articles, last 24 months); 73 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Technical Innovations and Patient Support in Radiation Oncology is published by Elsevier and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Advanced Radiotherapy Techniques, Advances in Oncology and Radiotherapy and Radiation Therapy and Dosimetry, together about 48.5% of its articles. Its main subfields are Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
An Official Journal of The European Society for Radiotherapy and OncologyTechnical Innovations & Patient Support in Radiation Oncology is an international, open access journal which brings together technology and patient care in the field of radiation oncology. The journal encompasses all topics of importance to radiation therapists, nurses and allied health professionals, including:* Treatment planning and workflows * Treatment delivery * Treatment verification * Patient care * Supportive care * Psycho-oncology * Education and training * Patient advocacy * Policy development and management * Patient reported outcome measures * Risk management * Radiotherapy quality management and control * Radiotherapy audit * Radiotherapy workflow management * PersonalisationThe journal publishes original research articles, case reports, practice development and health evaluation articles, review articles, short communications, technical notes, case series and reports, and correspondence.
From the journal's Aims & Scope
Research area (LetPub): Nursing-Oncology (nursing)
Editor-in-chief Aileen DufftonPublisher website
Editorial board by country: none in mainland China; most named Australia 7, Netherlands 6, United Kingdom 5, Canada 5, Ireland 4 (39 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Radiotherapy TechniquesPhysics and Astronomy27%
- Advances in Oncology and RadiotherapyMedicine14.1%
- Radiation Therapy and DosimetryMedicine7.4%
- Prostate Cancer Diagnosis and TreatmentMedicine5.6%
- Lung Cancer Diagnosis and TreatmentMedicine5.5%
- Head and Neck Cancer StudiesMedicine4%
- Management of metastatic bone diseaseMedicine4%
- Radiology practices and educationMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2Publisher website ·
- CiteScore 2026-06
- 3.6LetPub ·
- CiteScore (publisher)
- 3.6Publisher website ·
- SJR 2026-06
- 0.62LetPub ·
- SNIP 2026-06
- 0.89LetPub ·
- h-index
- 27OpenAlex ·
- i10-index
- 101OpenAlex ·
- 2-year mean citedness
- 1.32OpenAlex ·
- Self-citation rate
- 15%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 67LetPub ·
Articles by year OpenAlex count · 434 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 65 | 65 | 12 |
| 2025 | 73 | 73 | 72 |
| 2024 | 65 | 65 | 183 |
| 2023 | 35 | 35 | 187 |
| 2022 | 52 | 52 | 669 |
| 2021 | 47 | 47 | 618 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
89 daysMedian, submission to acceptance · P25–P75 72 days – 123 days
- Acceptance to online
- median 2 days (101 articles)
- Submission to online
- median 94 days
- Sample
- 101 articles with submission and acceptance dates (158 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 18 weeksLetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- First decision after review
- 34 daysPublisher website ·
- Submission to acceptance
- 92 daysPublisher website ·
- Acceptance to publication
- 4 daysPublisher website ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,410 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 1,410 / EUR 1,290 / GBP 1,130 / JPY 174,880 | — | — | |
| LetPub | EUR 1,290 | Yes | — | |
| Publisher website | USD 1,890 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 1
Article types accepted16, with length limits
- case report1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…main text ≤ 1,500 words
- case reports and case series5. Case reports and case seriesLength not stated
- correspondence7. CorrespondenceLength not stated
- guidelines / delphi consensus recommendations4. Guidelines / Delphi consensus recommendations (5000 words max., excluding the reference list; note: for exceptional surveys only, aim for 3000 words)Length not stated
- original research article1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…Length not stated
- practice development and health evaluation articles6. Practice development and health evaluation articles (max. 2500 words)Length not stated
- research article1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…Length not stated
- research articles1. Research articles (max. 3000 words)Length not stated
- review1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…Length not stated
- review article1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…Length not stated
- review articles3. Review articles (max. 5000 words, excluding references)Length not stated
- short communication1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…Length not stated
- short communications and technical notes2. Short communications and technical notes (max. 2000 words)Length not stated
- survey1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…main text ≤ 3,000 words
- systematic review1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…Length not stated
- technical note1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints, Trial registration / reporting guidelines
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Authors must follow Elsevier's Publishing Ethics Policy. Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Free preprint posting service on SSRN offered. Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·- Trial registration / reporting guidelines Study design and reporting guidelines
Technical Innovations and Patient Support in Radiation Oncology recommends consulting the relevant study design and reporting guidelines before preparing your manuscript. Technical Innovations and Patient Support in Radiation Oncology requires a completed checklist as part of your submission, for the following study types: • Randomised trials - CONSORT • Observational studies - STROBE • Clinical G…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- Netherlands
- Language
- English
- ISSN
- 2405-6324
- Society / sponsor
- European Society for Radiotherapy and Oncology
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Technical Innovations and Patient Support in Radiation Oncology
What CAS zone is Technical Innovations and Patient Support in Radiation Oncology in?
In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Technical Innovations and Patient Support in Radiation Oncology?
The journal's website gives an impact factor of 2; this is the journal's own figure, as LetPub lists none for it; CiteScore 3.6, h-index 27.
How long does peer review take at Technical Innovations and Patient Support in Radiation Oncology?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 89 days (interquartile range 72–123 days); authors report an average review time of about 18 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Technical Innovations and Patient Support in Radiation Oncology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 1. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Technical Innovations and Patient Support in Radiation Oncology based?
Of the 39 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Australia (7), Netherlands (6) and United Kingdom (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Technical Innovations and Patient Support in Radiation Oncology?
According to LetPub and DOAJ records, Technical Innovations and Patient Support in Radiation Oncology is indexed in ESCI, Scopus and DOAJ.
Is Technical Innovations and Patient Support in Radiation Oncology open access, and what is the APC?
Technical Innovations and Patient Support in Radiation Oncology is a fully open-access journal. APC about USD 1,410.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .